Disease | kaposi sarcoma |
Phenotype | C0024305|non-hodgkin lymphoma |
Sentences | 3 |
PubMedID- 20417362 | Background: primary effusion lymphoma (pel) is a highly malignant non-hodgkin lymphoma associated with kaposi's sarcoma-associated herpesvirus/human herpesvirus-8 infection (kshv/hhv-8). |
PubMedID- 22901001 | As this could not be estimated for other sites, we assumed the following times (in parentheses) for the specific cancer sites: non-hodgkin lymphoma (5 years), cancers of the larynx, kaposi sarcoma, cervix uteri, corpus uteri, testis, thyroid, hodgkin lymphoma and multiple myeloma (1 year). |
PubMedID- 25714364 | The most frequent cancers were non-hodgkin lymphoma (nhl; 44% of adc), kaposi's sarcoma (40% of adc), and lung cancer (20% of nadc). |
Page: 1